位置:首页 > 蛋白库 > RARA_CANLF
RARA_CANLF
ID   RARA_CANLF              Reviewed;         462 AA.
AC   Q5FBR4;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 1.
DT   25-MAY-2022, entry version 106.
DE   RecName: Full=Retinoic acid receptor alpha;
DE            Short=RAR-alpha;
DE   AltName: Full=Nuclear receptor subfamily 1 group B member 1;
GN   Name=RARA; Synonyms=NR1B1;
OS   Canis lupus familiaris (Dog) (Canis familiaris).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Canis.
OX   NCBI_TaxID=9615;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spleen;
RA   Miyajima N., Watanabe M., Sugano S., Sasaki N.;
RT   "Molecular cloning of canine highly similar retinoic acid receptor alpha.";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Receptor for retinoic acid. Retinoic acid receptors bind as
CC       heterodimers to their target response elements in response to their
CC       ligands, all-trans or 9-cis retinoic acid, and regulate gene expression
CC       in various biological processes. The RXR/RAR heterodimers bind to the
CC       retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3'
CC       sites known as DR1-DR5. In the absence of ligand, the RXR-RAR
CC       heterodimers associate with a multiprotein complex containing
CC       transcription corepressors that induce histone deacetylation, chromatin
CC       condensation and transcriptional suppression. On ligand binding, the
CC       corepressors dissociate from the receptors and associate with the
CC       coactivators leading to transcriptional activation. Formation of
CC       heterocomplex with histone deacetylases might lead to inhibition of
CC       RARE DNA element binding and to transcriptional repression (By
CC       similarity). Transcriptional activation and RARE DNA element binding
CC       might be supported by the transcription factor KLF2 (By similarity).
CC       RARA plays an essential role in the regulation of retinoic acid-induced
CC       germ cell development during spermatogenesis. Has a role in the
CC       survival of early spermatocytes at the beginning prophase of meiosis.
CC       In Sertoli cells, may promote the survival and development of early
CC       meiotic prophase spermatocytes. Together with RXRA, positively
CC       regulates microRNA-10a expression, thereby inhibiting the GATA6/VCAM1
CC       signaling response to pulsatile shear stress in vascular endothelial
CC       cells (By similarity). In association with HDAC3, HDAC5 and HDAC7
CC       corepressors, plays a role in the repression of microRNA-10a and
CC       thereby promotes the inflammatory response (By similarity).
CC       {ECO:0000250|UniProtKB:P10276, ECO:0000250|UniProtKB:P11416}.
CC   -!- SUBUNIT: Heterodimer; with RXRA (By similarity). Binds DNA
CC       preferentially as a heterodimer (By similarity). RXRA serves as
CC       enhancer to induce RARA binding to RARE (By similarity). Interacts with
CC       NCOA3 and NCOA6 coactivators, leading to a strong increase of
CC       transcription of target genes (By similarity). Interacts with NCOA7 in
CC       a ligand-inducible manner (By similarity). Interacts (via the ligand-
CC       binding domain) with PRAME; interaction is direct and ligand (retinoic
CC       acid)-dependent (By similarity). Interacts with PRKAR1A; the
CC       interaction negatively regulates RARA transcriptional activity (By
CC       similarity). Interacts with NCOR1 and NCOR2; the interaction occurs in
CC       the absence of ligand and represses transcriptional activity (By
CC       similarity). Interacts with NCOA3 and NCOA6 coactivators, leading to a
CC       strong increase of transcription of target genes (By similarity).
CC       Interacts with CDK7; the interaction is enhanced by interaction with
CC       GTF2H3 (By similarity). Interacts with GTF2H3; the interaction requires
CC       prior phosphorylation on Ser-369 which then enhances interaction with
CC       CDK7. Interacts with PRMT2 (By similarity). Interacts with LRIF1 (By
CC       similarity). Interacts with ASXL1 and NCOA1 (By similarity). Interacts
CC       with ACTN4 (By similarity). In a complex with HDAC3, HDAC5 and HDAC7;
CC       the HDACs serve as corepressors of RARA, causing its deacetylation and
CC       inhibition of RARE DNA element binding; association with HDAC3, HDAC5
CC       and HDAC7 is increased upon oscillatory shear stress (By similarity).
CC       In the absence of hormonal ligand, interacts with TACC1 (By
CC       similarity). {ECO:0000250|UniProtKB:P10276,
CC       ECO:0000250|UniProtKB:P11416}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00407}.
CC       Cytoplasm {ECO:0000250|UniProtKB:P10276}. Note=Nuclear localization
CC       depends on ligand binding, phosphorylation and sumoylation.
CC       Translocation to the nucleus is dependent on activation of PKC and the
CC       downstream MAPK phosphorylation (By similarity). Increased nuclear
CC       localization upon pulsatile shear stress (By similarity).
CC       {ECO:0000250|UniProtKB:P10276}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a
CC       DNA-binding domain and a C-terminal ligand-binding domain.
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000250|UniProtKB:P10276}.
CC   -!- PTM: Phosphorylated on serine and threonine residues. Phosphorylation
CC       does not change during cell cycle. Phosphorylation on Ser-77 is crucial
CC       for the N-terminal AF1 transcriptional activity. Under stress
CC       conditions, MAPK8 enhances phosphorylation on Thr-181, Ser-445 and Ser-
CC       461 leading to RARA ubiquitination and degradation. Phosphorylation by
CC       AKT1 inhibits the transactivation activity. On retinoic acid
CC       stimulation, phosphorylation on Ser-369 by RPS6KA5 promotes interaction
CC       with GTF2H3 and the CDK7-mediated phosphorylation of Ser-77 (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Sumoylated with SUMO2, mainly on Lys-399 which is also required
CC       for SENP6 binding. On all-trans retinoic acid (ATRA) binding, a
CC       confromational change may occur that allows sumoylation on two
CC       additional site, Lys-166 and Lys-171. Probably desumoylated by SENP6.
CC       Sumoylation levels determine nuclear localization and regulate ATRA-
CC       mediated transcriptional activity (By similarity). {ECO:0000250}.
CC   -!- PTM: Acetylated; acetylation is increased upon pulsatile shear stress
CC       and decreased upon oscillatory shear stress.
CC       {ECO:0000250|UniProtKB:P10276}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB179779; BAD89859.1; -; mRNA.
DR   RefSeq; NP_001012663.1; NM_001012645.1.
DR   AlphaFoldDB; Q5FBR4; -.
DR   SMR; Q5FBR4; -.
DR   STRING; 9615.ENSCAFP00000010481; -.
DR   GeneID; 480526; -.
DR   KEGG; cfa:480526; -.
DR   CTD; 5914; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   InParanoid; Q5FBR4; -.
DR   Proteomes; UP000002254; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0004879; F:nuclear receptor activity; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0048384; P:retinoic acid receptor signaling pathway; IBA:GO_Central.
DR   Gene3D; 1.10.565.10; -; 1.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR003078; Retinoic_acid_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01292; RETNOICACIDR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm; DNA-binding; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Receptor; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..462
FT                   /note="Retinoic acid receptor alpha"
FT                   /id="PRO_0000053460"
FT   DOMAIN          183..417
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        88..153
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         88..108
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         124..148
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..87
FT                   /note="Modulating"
FT   REGION          52..77
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          154..182
FT                   /note="Hinge"
FT   REGION          419..462
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           408..416
FT                   /note="9aaTAD"
FT                   /evidence="ECO:0000250|UniProtKB:P10276"
FT   COMPBIAS        52..71
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        447..462
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         77
FT                   /note="Phosphoserine; by CDK7"
FT                   /evidence="ECO:0000250|UniProtKB:P11416"
FT   MOD_RES         96
FT                   /note="Phosphoserine; by PKB/AKT1"
FT                   /evidence="ECO:0000250|UniProtKB:P10276"
FT   MOD_RES         219
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P10276"
FT   MOD_RES         369
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P11416"
FT   CROSSLNK        166
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        171
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        399
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   462 AA;  50771 MW;  8E63EE98C4E0FB4A CRC64;
     MASNSSSCPT PGGGHLNGYP VPPYAFFFPP MLGGLSPPGA LTTLQHQLPV SGYSTPSPAT
     IETQSSSSEE IVPSPPSPPP LPRIYKPCFV CQDKSSGYHY GVSACEGCKG FFRRSIQKNM
     VYTCHRDKNC IINKVTRNRC QYCRLQKCFE VGMSKESVRN DRNKKKKEAP KPECSESYTL
     TPEVGELIEK VRKAHQETFP ALCQLGKYTT NNSSEQRVSL DIDLWDKFSE LSTKCIIKTV
     EFAKQLPGFT TLTIADQITL LKAACLDILI LRICTRYTPE QDTMTFSEGL TLNRTQMHKA
     GFGPLTDLVF AFANQLLPLE MDDAETGLLS AICLICGDRQ DLEQPDRVDM LQEPLLEALK
     VYVRKRRPSR PHMFPKMLMK ITDLRSISAK GAERVITLKM EIPGSMPPLI QEMLENSEGL
     DTLSGQPGGG GRDGGGLAPP PGSCSPSLSP SSNRSSPATH SP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024